THE MAIN ACTIVITIES:

1. Monitoring safety of drugs in RA,

2. Detection, assessment, understanding  of ADR reports,

3. Expertise of documents related to safety of drugs such as:

  • PSUR,

  • RMP,

  • DHPL,

4.  Publishing  “Drug safety” bulletin,

5. Development of educational and training materials on medicine safety,

6. Accepting patient’s inquiries and providing feedbacks on drug safety by using hot line calls.

 

HEAD OF THE DEPARTMENT:

Naira Romanova

Pharmacist

Phone: (+374 10) 231682, 230896, 234732, 232091, 123

Hot Line: (+374 10) 20-05-05, (+374 96) 22-05-05

E-mail: ,

 

LEGAL BASIS FOR ACTIVITY:

  1. Republic of Armenia Law "On Medicines

  2. Decree of the Government of the Republic of Armenia N 150-N February 28, 2019, «On designation a body responsible for organization and conduction the assessment and inspection in the field of state regulation of medicinal products circulation»

  3. Decree of the Government of the Republic of Armenia N 162-N of February 28, 2019 «On adopting the rules for medicinal product state registration, reregistration, extension of the registration certificate, to refuse registration, reregistration, extension of the registration certificate, suspension of registration, withdraw of registration, the rules of the assessment for these proposes as well as the rule of post registration changes’ submission and assessment, the list of necessary documents, the list of changes of the registered medicinal products do not require new registration, the rule of inspection and recognition of other countries competent authorities inspection reports and on repeal of the Decree of the Government of the Republic of Armenia N 347 of April 25, 2001»

  4. Decree of the Government of the Republic of Armenia N 166-N of February 28, 2019 «On adopting the fees in the Republic of Armenia for assessments in the field of medicinal products state regulation»

  5. Order of the Ministry of Health of the Republic of Armenia N23-N of May 17 2017 on approving “The order of recording and reporting cases of adverse reactions, lack of effectiveness, misuse and suspect on falsification of medicines; collecting, reporting, monitoring, submitting reports and analyzing data on adverse reactions of medicines, approving the form of the register of adverse reaction and form of reporting of adverse reactions, lack of effectiveness, misuse and suspect on falsification of medicines

 

DRUG SAFETY MONITORING